No Data
No Data
CICC: Maintaining China Resources Healthcare's (01515) “Outperform the Industry” Rating Target Price of HK$5.6
The Zhitong Finance App learned that CICC released a research report stating that it maintained China Resources Healthcare's (01515) “outperforming the industry” rating and maintained 2024/2025 net profit of RMB551/715 billion, an increase of 113.8%/29.8% over the previous year, with a target price of HK$5.6. The company announced its 2023 results: revenue of RMB 10.108 billion, up 27.9% year on year; net profit to mother of RMB 258 million, a decrease of 3.1% year on year, in line with the forecast. CICC's main views are as follows: further expansion of the hospital network layout, hospital industry
CR MEDICAL To Go Ex-Dividend On June 7th, 2024 With 0.0661 HKD Dividend Per Share
March 20th - $CR MEDICAL(01515.HK)$ is trading ex-dividend on June 7th, 2024. Shareholders of record on June 11th, 2024 will receive 0.0661 HKD dividend per share on July 19th, 2024. The ex-divide
China Resources Medical will pay a final dividend of $0.06 per share on July 19
China Resources Medical (01515) announced that it will pay a final dividend of RMB 0.06 per share for the year ended December 31, 2023 on July 19, 2024.
China Resources Healthcare (01515) will pay a final dividend of $0.06 per share on July 19
According to Zhitong Finance App, China Resources Healthcare (01515) announced that it will pay a final dividend of RMB 0.06 per share for the year ended December 31, 2023 on July 19, 2024.
China Resources Healthcare (01515) announced annual results, with shareholders' share profit of 258 million yuan
China Resources Healthcare (01515) announced its annual results for the year ended December 31, 2023. The group reaped benefits, people...
CR MEDICAL: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
No Data